Elimination half-life may explain the relative efficacy of boceprevir and telaprevir in the treatment of hepatitis C virus genotype 1

Clin Infect Dis. 2013 Jun;56(11):1677-8. doi: 10.1093/cid/cit087. Epub 2013 Feb 15.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Genotype*
  • Hepacivirus / genetics*
  • Hepatitis C / drug therapy*
  • Humans
  • Oligopeptides / therapeutic use*
  • Proline / analogs & derivatives*

Substances

  • Antiviral Agents
  • Oligopeptides
  • Proline